Editorial: Familial papillary thyroid cancer - Many syndromes, too many genes?

被引:51
作者
Eng, C
机构
[1] Ohio State Univ, Ctr Canc, Clin Canc Genet Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Canc, Human Canc Genet Program, Columbus, OH 43210 USA
[3] Univ Cambridge, Canc Res Campaign, Human Canc Genet Res Grp, Cambridge CB2 2QQ, England
关键词
D O I
10.1210/jc.85.5.1755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1755 / 1757
页数:3
相关论文
共 12 条
[1]   Familial nontoxic multinodular thyroid goiter locus maps to chromosome 149 but does not account for familial nonmedullary thyroid cancer [J].
Bignell, GR ;
Canzian, F ;
Shayeghi, M ;
Stark, M ;
Shugart, YY ;
Biggs, P ;
Mangion, J ;
Hamoudi, R ;
Rosenblatt, J ;
Buu, P ;
Sun, S ;
Stoffer, SS ;
Goldgar, DE ;
Romeo, G ;
Houlston, RS ;
Narod, SA ;
Stratton, MR ;
Foulkes, WD .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (05) :1123-1130
[2]   A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2 [J].
Canzian, F ;
Amati, P ;
Harach, HR ;
Kraimps, JL ;
Lesueur, F ;
Barbier, J ;
Levillain, P ;
Romeo, G ;
Bonneau, D .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (06) :1743-1748
[3]   HEREDITARY RENAL-CELL CARCINOMA ASSOCIATED WITH A CHROMOSOMAL TRANSLOCATION [J].
COHEN, AJ ;
LI, FP ;
BERG, S ;
MARCHETTO, DJ ;
TSAI, S ;
JACOBS, SC ;
BROWN, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (11) :592-595
[4]   The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis [J].
Eng, C ;
Clayton, D ;
Schuffenecker, I ;
Lenoir, G ;
Cote, G ;
Gagel, RF ;
vanAmstel, HKP ;
Lips, CJM ;
Nishisho, I ;
Takai, SI ;
Marsh, DJ ;
Robinson, BG ;
FrankRaue, K ;
Raue, F ;
Xue, FY ;
Noll, WW ;
Romei, C ;
Pacini, F ;
Fink, M ;
Niederle, B ;
Zedenius, J ;
Nordenskjold, M ;
Komminoth, P ;
Hendy, GN ;
Gharib, H ;
Thibodeau, SN ;
Lacroix, A ;
Frilling, A ;
Ponder, BAJ ;
Mulligan, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19) :1575-1579
[5]   Genetic heterogeneity in familial nonmedullary thyroid carcinoma:: Exclusion of linkage to RET, MNG1, and TCO in 56 families [J].
Lesueur, F ;
Stark, M ;
Tocco, T ;
Ayadi, H ;
Delisle, MJ ;
Goldgar, DE ;
Schlumberger, M ;
Romeo, G ;
Canzian, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (06) :2157-2162
[6]   Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome [J].
Malchoff, CD ;
Sarfarazi, M ;
Tendler, B ;
Forouhar, F ;
Whalen, G ;
Joshi, V ;
Arnold, A ;
Malchoff, DM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1758-1764
[7]   Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli [J].
Malchoff, CD ;
Sarfarazi, M ;
Tendler, B ;
Forouhar, F ;
Whalen, G ;
Malchoff, DM .
THYROID, 1999, 9 (03) :247-252
[8]   Germline PTEN mutations in Cowden syndrome-like families [J].
Marsh, DJ ;
Dahia, PLM ;
Caron, S ;
Kum, JB ;
Frayling, IM ;
Tomlinson, IPM ;
Hughes, KS ;
Eeles, RA ;
Hodgson, SV ;
Murday, VA ;
Houlston, R ;
Eng, C .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (11) :881-885
[9]   Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation [J].
Marsh, DJ ;
Coulon, V ;
Lunetta, KL ;
Rocca-Serra, P ;
Dahia, PLM ;
Zheng, ZM ;
Liaw, D ;
Caron, S ;
Duboué, B ;
Lin, AY ;
Richardson, AL ;
Bonnetblanc, JM ;
Bressieux, JM ;
Cabarrot-Moreau, A ;
Chompret, A ;
Demange, L ;
Eeles, RA ;
Yahanda, AM ;
Fearon, ER ;
Fricker, JP ;
Gorlin, RJ ;
Hodgson, SV ;
Huson, S ;
Lacombe, D ;
LePrat, F ;
Odent, S ;
Toulouse, C ;
Olopade, OI ;
Sobol, H ;
Tishler, S ;
Woods, CG ;
Robinson, BG ;
Weber, HC ;
Parsons, R ;
Peacocke, M ;
Longy, M ;
Eng, C .
HUMAN MOLECULAR GENETICS, 1998, 7 (03) :507-515
[10]   Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility [J].
Offit, K ;
Biesecker, BB ;
Burt, RW ;
Clayton, EW ;
Garber, JE ;
Kahn, MJE .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1730-1736